# Effect of Mebo Dressing Versus Standard Care on Managing Donor and Recipient Sites of Split-thickness Skin Graft

> **NCT02737943** · PHASE1 · UNKNOWN · sponsor: **Zagazig University** · enrollment: 40 (estimated)

## Conditions studied

- Burns

## Interventions

- **DRUG:** Moist Exposed Burn Ointment (MEBO)
- **DRUG:** Zagazig

## Key facts

- **NCT ID:** NCT02737943
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2019-06
- **Final completion:** 2019-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02737943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02737943, "Effect of Mebo Dressing Versus Standard Care on Managing Donor and Recipient Sites of Split-thickness Skin Graft". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02737943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*